Leila Alland
CIK 1825216 · Chief Medical Officer · last filed 2026-02-02
Leila Alland is a Chief Medical Officer who has filed 21 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing shows the insider sold $92.0K of ABEO on Feb 2, 2026. Across all open-market trades the lifetime net is −$921.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.01M
2
21
-$921.6K
Holdings By Company
Recent Filings
21 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-02-02 | ABEO | Sell (S) | −18,065 | -$92.0K | EDGAR |
| 2026-01-27 | ABEO | Grant (A) | +37,313 | $0 | EDGAR |
| 2025-02-03 | ABEO | Grant (A) | +36,101 | $0 | EDGAR |
| 2024-08-27 | ABEO | Grant (A) | +11,797 | $0 | EDGAR |
| 2024-07-09 | ABEO | Grant (A) | +23,611 | $0 | EDGAR |
| 2024-05-20 | ABEO | Buy (P) | +11,000 | $51.8K | EDGAR |
| 2023-09-29 | ABEO | Sell (S) | −7,246 | -$28.3K | EDGAR |
| 2023-09-18 | PMVP | Sell (S) | −6,291 | -$41.6K | EDGAR |
| 2023-06-16 | ABEO | Grant (A) | +58,689 | $271.1K | EDGAR |
| 2023-05-15 | PMVP | Grant (A) | — | $0 | EDGAR |